Making sense of post-treatment surveillance in head and neck cancer: when and what of follow-up

Cancer Treatment Reviews

Volumn 35, Issue 8, 2009, Pages 744-753

  Manikantan, Kapila ^a   Khode, Shailesh ^a   Dwivedi, Raghav C ^b   Palav, Rajan ^a   Nutting, Chris M ^b   Rhys Evans, Peter ^b   Harrington, Kevin J ^b   Kazi, Rehan ^b  

^a SIR J J GROUP OF HOSPITALS   (India)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

Author keywords

Head and neck cancer; Recommendations; Surveillance

Indexed keywords

ANTINEOPLASTIC AGENT; CA 125 ANTIGEN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; ELECTROLYTE; FLUORODEOXYGLUCOSE F 18; TUMOR MARKER;

ASPIRATION BIOPSY; BRONCHOSCOPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CINAHL; CLINICAL EXAMINATION; CLINICAL PRACTICE; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; COST BENEFIT ANALYSIS; DIFFUSION WEIGHTED IMAGING; EARLY DIAGNOSIS; ECHOGRAPHY; ELECTROLYTE BLOOD LEVEL; EMBASE; ENDOSCOPY; FOLLOW UP; HEAD AND NECK CANCER; HEAD AND NECK SURGERY; HEALTH CARE SYSTEM; HUMAN; HYPOTHYROIDISM; IMAGING SYSTEM; LIVER FUNCTION TEST; MEDICAL LITERATURE; MEDICAL SPECIALIST; MEDLINE; METASTASIS; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIODIC MEDICAL EXAMINATION; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; QUALITY OF LIFE; REVIEW; SCISEARCH; SOCIAL SUPPORT; SURGEON; THORAX RADIOGRAPHY; THYROID FUNCTION TEST; TIME;

CARCINOMA, SQUAMOUS CELL; COST-BENEFIT ANALYSIS; ENDOSCOPY; HEAD AND NECK NEOPLASMS; HUMANS; MAGNETIC RESONANCE IMAGING; OFFICE VISITS; POPULATION SURVEILLANCE; POSITRON-EMISSION TOMOGRAPHY; THYROID FUNCTION TESTS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 70449708996     PISSN: 03057372     EISSN: 15321967     Source Type: Journal    
DOI: 10.1016/j.ctrv.2009.08.007     Document Type: Review

References (70)

1. Ridge J.A. Squamous cancer of the head and neck: surgical treatment of local and regional recurrence. Semin Oncol 20 (1993) 419-429
2. Schwartz L., Ozsahin M., Zhang G., et al. Synchronous and metachronous head and neck carcinomas. Cancer 74 (1994) 1933-1938
3. Sturgis E., and Miller R. Second primary malignancies in the head and neck cancer patient. Ann Otol Rhinol Laryngol 104 (1995) 946-954
4. Vikram B., Strong E.W., Shah J.P., and Spiro R. Second malignant neoplasms in patients successfully treated with multimodality treatment for advanced head and neck cancer. Head Neck Surg 6 (1984) 734-737
5. Tepperman B.S., and Fitzpatrick P.J. Second respiratory and upper digestive tract cancer after oral cancer. Lancet 62 (1981) 547-549
6. DeVisscher A.V.M., and Manni J.J. Routine long-term follow-up in patients treated with curative intent for squamous cell carcinoma of the larynx, pharynx, and oral cavity. Arch Otolaryngol Head Neck Surg 120 (1994) 934-939
7. Boysen M., Lövdal O., Tausjö J., and Winther F. The value of follow-up in patients treated for squamous cell carcinoma of the head and neck. Eur J Cancer 28 (1992) 426-430
8. Schantz S.P., and Andersen P.E. Head and neck carcinoma. In: Johnson F.E., and Virgo K.S. (Eds). Cancer patient follow-up (1997), Mosby-Year Book Inc., St Louis, Mo 57-64
9. Boysen M. Value of follow-up in patients treated for squamous cell carcinomas of the oral cavity and oropharynx. Recent Results Cancer Res 134 (1994) 205-214
10. Loree T.R. Head and neck carcinoma: counterpoint. In: Johnson F.E., and Virgo K.S. (Eds). Cancer patient follow-up (1997), Mosby-Year Book Inc., St Louis, Mo 72.13
11. Weymuller Jr. E.A. Head and neck carcinoma: counterpoint. In: Johnson F.E., and Virgo K.S. (Eds). Cancer patient follow-up (1997), Mosby-Year Book Inc., St Louis, Mo 72-75
12. Jones A.S. Head and neck carcinoma: counterpoint. In: Johnson F.E., and Virgo K.S. (Eds). Cancer patient follow-up (1997), Mosby-Year Book Inc., St Louis, Mo 65-71
13. Johnson F.E., Johnson M.H., and Virgo K.S. Current follow-up strategies after potentially curative resection of upper aerodigestive tract epidermoid carcinoma: results of a survey of members of the society of head and neck surgeons. Int J Oncol 10 (1997) 927-931
14. Marchant F.E., Lowry L.D., Moffitt J.J., and Sabbagh R. Current national trends in the posttreatment follow-up of patients with squamous cell carcinoma of the head and neck. Am J Otolaryngol 14 (1993) 88-93
15. Boysen M., Natvig K., Winther F.o., and Tausjö J. Value of routine follow-up in patients treated for squamous cell carcinoma of the head and neck. J Otolaryngol 14 (1985) 211-214
16. Austin J.R. Carcinoma of the head and neck. In: Berger D.H., Feig B.W., and Fuhrman G.M. (Eds). The M.D. Anderson surgical oncology handbook (1995), Little Brown and Co Inc., Boston, Mass
17. Byers R.M. Head and neck cancer. In: Eiseman B., Robinson W.A., and Steele Jr. G. (Eds). Follow-up of the cancer patient (1982), Thieme-Stratton Inc., New York, NY 36-40
18. Coniglio J.U., and Netterville J.L. Guidelines for patient management. In: Bailey B.J., Johnson J.T., Pillsbury H.C., Kohut R.I., and Tardy Jr. M.E. (Eds). Head and neck surgery otolaryngology (1993), JB Lippincott, Philadelphia, Pa 1021-1028
19. Nakashima T. Head and neck carcinoma: counterpoint. In: Johnson F.E., and Virgo K.S. (Eds). Cancer patient follow-up (1997), Mosby-Year Book Inc., St Louis, Mo 64-65
20. Söderholm A.L., Lindqvist C., and Haglund C. Tumour markers and radiological examinations in the follow-up of patients with oral cancer. J Craniomaxillofac Surg 20 (1992) 211-215
21. Lara P.C., and Cuyǎs J.M. The role of squamous cell carcinoma antigen in the management of laryngeal and hypopharyngeal cancer. Cancer 76 (1995) 758-764
22. Engelen A.M., Stalpers L.J., Manni J.J., Riujs J.H., and van Daal W.A. Yearly chest radiography in the early detection of lung cancer following laryngeal cancer. Eur Arch Otorhinolaryngol 249 (1992) 364-369
23. Stalpers L.J., van Vierzen P.B., Brouns J.J., et al. The role of yearly chest radiography in the early detection of lung cancer following oral cancer. Int J Oral Maxillofac Surg 18 (1989) 99-103
24. Clinical Practice Guidelines Task Force. Clinical practice guidelines for the diagnosis and management of cancer of the head and neck. Pittsburgh, Pa: The American Society for Head and Neck Surgery, and Arlington, Va: Society of Head and Neck Surgeons; 1996.
25. Head and neck cancers. In: Fischer DS, editor. Follow-up of cancer: a handbook for physicians. 4th ed. Philadelphia, Pa: Lippincott-Raven Publishers; 1996.
26. Yuen A.P., Wei W.I., Wong S.H., and Ho W.K. Comprehensive analysis of nodal recurrence of advanced laryngeal carcinoma following surgery. Eur J Surg Oncol 22 (1996) 350-353
27. British Association of Head and Neck Oncologists. Practice care guidance for clinicians participating in the management of head and neck cancer patients in the UK. Drawn up by a Consensus Group of Practising Clinicians. Eur J Surg Oncol A (2001) S1-S17
28. Johnson F.E., Virgo K.S., Clemente M.F., Johnson M.H., and Paniello R.C. How tumor stage affects surgeons' surveillance strategies after surgery for carcinoma of the upper aerodigestive tract. Cancer 82 (1998) 1932-1937
29. Schwartz D.L., Barker Jr. J., Chansky K., et al. Postradiotherapy surveillance practice for head and neck squamous cell carcinoma - too much or too little?. Head Neck 25 (2003) 990-999
30. O'Meara W.P., Thiringer J.K., and Johnstone P.A. Follow-up of head and neck cancer patients post-radiotherapy. Radiother Oncol 66 (2003) 323-326
31. Cooney T.R., and Poulsen M.G. Is routine follow-up useful after combined-modality therapy for advanced head and neck cancer?. Arch Otolaryngol Head Neck Surg 125 (1999) 379-382
32. Johnson F.E., Johnson M.H., Clemente M.F., Paniello R.C., and Virgo K.S. Geographical variation in surveillance strategies after curative-intent surgery for upper aerodigestive tract cancer. Ann Surg Oncol 13 (2006) 1063-1071
33. Kissun D., Magennis P., Lowe D., Brown J.S., Vaughan E.D., and Rogers S.N. Timing and presentation of recurrent oral and oropharyngeal squamous cell carcinoma and awareness in the outpatient clinic. Br J Oral Maxillofac Surg 44 (2006) 371-376
34. Pearlmann N.W. Treatment outcome in recurrent head and neck cancer. Arch Surg 114 (1979) 39-42
35. FSO task force. Posttreatment surveillance of adults with squamous-cell carcinoma of the upper aerodigestive tract. Fr ORL 89 (2005) 128
36. Mukherji S.K., Mancuso A.A., Kotzur I.M., et al. Radiologic appearance of the irradiated larynx. Part II. Primary site response. Radiology 193 (1994) 149-154
37. Pameijer F.A., Hermans R., Mancuso A.A., et al. Pre- and post-radiotherapy computed tomography in laryngeal cancer: imaging-based prediction of local failure. Int J Radiat Oncol Biol Phys 45 (1999) 359-366
38. Westhofen M. Ultrasound B-scans in the follow-up of head and neck tumors. Head Neck Surg 9 (1987) 272-278
39. Ahuja A., Leung S.F., Ying M., and Metreweli C. Echography of metastatic nodes treated by radiotherapy. J Laryngol Otol 113 (1999) 993-998
40. Steinkamp H.J., Maurer J., Cornehl M., Knobber D., Hettwer H., and Felix R. Recurrent cervical lymphadenopathy: differential diagnosis with color-duplex sonography. Eur Arch Oto-Rhino-Laryngol 251 (1994) 404-409
41. Warner G.C., and Cox G.J. Evaluation of chest radiography versus chest computed tomography in screening for pulmonary malignancy in advanced head and neck cancer. J Otolaryngol 32 (2003) 107-109
42. Hsu Y.B., Chu P.Y., Liu J.C., et al. Role of chest computed tomography in head and neck cancer. Arch Otolaryngol Head Neck Surg 134 (2008) 1050-1054
43. Mercader V.P., Gatenby R.A., Mohr R.M., Fisher M.S., and Caroline D.F. CT surveillance of the thorax in patients with squamous cell carcinoma of the head and neck: a preliminary experience. J Comput Assist Tomogr 21 (1997) 412-417
44. Steinkamp H.J., Knöbber D., Schedel H., et al. Palpation and sonography in after-care of head-neck tumor patients: comparison of ultrasound tumor entity parameters. Laryngorhinootologie 72 (1993) 431-438
45. Di Martino E., Hausmann R., Krombach G.A., et al. Relevance of colour-duplex echography for detection and therapy of recurrences in the follow-up of head and neck cancer. Laryngorhinootologie 81 (2002) 866-874
46. Sharwani A., Jerjes W., Salih V., et al. Fluorescence spectroscopy combined with 5-aminolevulinic acid-induced proporphyrin IX fluorescence in detecting oral premalignancy. J Photochem Photobiol B 83 (2006) 27
47. Hermans R., Pameijer F.A., Mancuso A.A., et al. Laryngeal or hypopharyngeal squamous cell carcinoma: can follow-up CT after definitive radiotherapy be used to detect local failure earlier than clinical examination alone?. Radiology 214 (2000) 683-687
48. Misiti A., Macori F., Caimi M., et al. Computerized tomography in the evaluation of the larynx after surgical treatment and irradiation. Radiol Med 94 (1997) 600-606
49. Hamstra D.A., Rehemtulla A., and Ross B.D. Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology. J Clin Oncol 25 (2007) 4104-4109
50. Wang J., Takashima S., Takayama F., et al. Head and neck lesions: characterization with diffusion weighted echo-planar MR imaging. Radiology 220 (2001) 621-630
51. Kostakoglu L., and Goldsmith S.J. PET in the assessment of therapy response in patients with carcinoma of the head and neck and of the esophagus. J Nucl Med 45 (2004) 56-68
52. Schoder H., Yeung H.W.D., Gonen M., et al. Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. Radiology 231 (2004) 65-72
53. Gordin A., Daitzchman M., Doweck I., et al. Fluorodeoxyglucose-positron emission tomography/computed tomography imaging in patients with carcinoma of the larynx: diagnostic accuracy and impact on clinical management. Laryngoscope 116 (2006) 273-278
54. Ong S.C., Schöder H., Lee N.Y., et al. Clinical utility of 18F-FDG PET/CT in assessing the neck after concurrent chemoradiotherapy for loco-regional advanced head and neck cancer. J Nucl Med 49 (2008) 532-540
55. Isles M.G., McConkey C., and Mehanna H.M. A systematic review and meta-analysis of the role of positron emission tomography in the follow-up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy. Clin Otolaryngol 33 (2008) 210-222
56. Abgral R., Querellou S., Potard G., et al. Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up?. J Nucl Med 50 (2009) 24-29
57. Haughey B.H., Gates G.A., Arfken C.L., and Harvey J. Meta-analysis of second malignant tumors in head and neck cancer: the case for an endoscopic screening protocol. Ann Otol Rhinol Laryngol 101 (1992) 105-112
58. Rachmat L., Vreeburg G.C., de Vries N., et al. The value of twice yearly bronchoscopy in the work-up and Follow-up of patients with Laryngeal cancer. Eur J Cancer 29A (1993) 1096-1099
59. Chao S.S., Loh K.S., and Tan L.K.S. Modalities of surveillance in treated nasopharyngeal cancer. Otolaryngol Head Neck Surg 129 (2003) 61-64
60. Guardiola E., Pivot X., Dassonville O., et al. Is routine triple endoscopy for head and neck carcinoma patients necessary in light of a negative chest computed tomography scan?. Cancer 101 (2004) 2028-2033
61. Straka M.B., Wagner R.L., Johnson J.T., Kachman K.K., and Eibling D.E. The lack of utility of a tumor marker panel in head and neck carcinoma. Squamous cell carcinoma antigen, carcinoembryonic antigen, lipid-associated sialic acid and CA-125. Arch Otolaryngol Head Neck Surg 118 (1992) 802-805
62. Snyderman C.H., D'Amico F., Wagner R., and Eibling D.E. A reappraisal of the squamous cell carcinoma antigen as a tumor marker in head and neck cancer. Arch Otolaryngol Head Neck Surg 121 (1995) 1294-1297
63. Krimmel M., Hoffmann J., Krimmel C., Cornelius C.P., and Schwenzer N. Relevance of SCC-Ag, CEA, CA 19.9 and CA 125 for diagnosis and follow-up in oral cancer. J Craniomaxxilofac Surg 26 (1998) 243-248
64. Zohar Y., Tovim R.B., Laurian N., and Laurian L. Thyroid function following radiation and surgical therapy in head and neck malignancy. Head Neck 6 (1984) 948-952
65. Palmer B.V., Gaggar N., and Shaw H.J. Thyroid function after radiotherapy and laryngectomy for carcinoma of the larynx. Head Neck Surg 4 (1981) 13-15
66. Aich R.K., Ranjan D.A., Pal S., Naha B.L., and Amitabh R. Iatrogenic hypothyroidism: a consequence of external beam radiotherapy to the head & neck malignancies. J Cancer Res Ther 1 (2005) 142-146
67. Cetinayak O., Akman F., Kentli S., et al. Assessment of treatment-related thyroid dysfunction in patients with head and neck cancer. Tumori 94 (2008) 19-23
68. Garcia-Serra A., Amdur R.J., Morris C.G., Mazzaferri E., and Mendenhall W.M. Thyroid function should be monitored following radiotherapy to the low neck. Am J Clin Oncol 28 (2005) 255-258
69. Virgo K.S., Paniello R.C., and Johnson F.E. Costs of posttreatment surveillance for patients with upper aerodigestive tract cancer. Arch Otolaryngol Head Neck Surg 124 (1998) 564-572
70. NCCN Clinical Practice Guidelines in Oncology. Head and Neck Cancers - v.2.2008.